Skip to content
OpenCapital
Get started

Envista Holdings Corporation NVST Trading Securities in Marketable Securities

Trading Securities in Marketable Securities at other companies

Medtronic logo
MedtronicMDT
——

Other financials

Income statement

See full
Revenue$705.5M+14.4%
Gross profit$390.1M+16.1%
Operating income$62.5M+60.3%
Net income$38.7M+115%
EPS (diluted)$0.23+130%

Balance sheet

See full
Cash & equivalents$1.1B+0.5%
Total debt$1.6B+1.8%
Total equity$3.1B+1.4%
Total assets$5.6B+2.0%

Cash flow

See full
Operating cash flow-$3.3M-1,200%
CapEx$12.5M+112%
Free cash flow-$15.8M-182%

Valuation

See full
Market cap$4.11B+39.9%

Profitability

See full
Gross margin54.9%+0.9pp
Operating margin8.5%+4.6pp
Net margin2.4%+1.2pp
FCF margin7.8%-2.9pp

Returns & leverage

See full
Return on equity2.2%+1.1pp
Debt / equity0.5×0.0×
Current ratio2.4×+0.3×

Where this comes from

Reported directly by Envista Holdings Corporation in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount.

The official record: Envista Holdings Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envista Holdings Corporation's trading securities in marketable securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Envista Holdings Corporation's trading securities in marketable securities?
Envista Holdings Corporation (NVST) reported trading securities in marketable securities of $26.4M in Q1 2026.
How has Envista Holdings Corporation's trading securities in marketable securities changed year-over-year?
Envista Holdings Corporation's trading securities in marketable securities decreased by 2.6% year-over-year, from $27.1M to $26.4M.
What is the long-term trend for Envista Holdings Corporation's trading securities in marketable securities?
Over 2 years (2023 to 2025), Envista Holdings Corporation's trading securities in marketable securities has grown at a 0.3% compound annual growth rate (CAGR), from $28.6M to $28.8M.